“…Two lines of evidence support this conclusion: comparative studies using PCDD, PCDF, and PCB congeners show that potency to cause immune suppression correlates with the binding affinity for the AhR (25)(26)(27)(28)(29); and studies using mice with a defined Ah genotype show that mice with high affinity AhR (e.g., Ahbb C57BI/6 mice) are more sensitive to immune suppression by these compounds than mice with lower affinity AhR (e.g., Ahdd DBA/2 mice or Ahdd congenic C57BI/6 mice) (8,25,26,29). AhR-dependent responses include suppression of the T-cell-dependent antibody response to SRBC (8,(25)(26)(27)(28)30,31), suppression of the T-cell-independent antibody response to trinitrophenyl-lipopolysaccharide (8), suppression of the cytotoxic T lymphocyte (CTL) response to allogeneic tumor cells (29,32) bone marrow toxicity (33), and suppression of the cytotoxic responses of activated neutrophils (34 however, the specific cellular defects induced by TCDD have not been fully elucidated despite considerable research. One of the problems has been a difficulty in demonstrating direct effects of TCDD on in vitro responses of lymphoid cells (35,36).…”